The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index; 1 of the 6 sources its claims cite were checked for support.
Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man
Open accessAbstract
The steady-state basal plasma glucose and insulin concentrations are determined by their interaction in a feedback loop. A computer-solved model has been used to predict the homeostatic concentrations which arise from varying degrees beta-cell deficiency and insulin resistance. Comparison of a patient's fasting values with the model's predictions allows a quantitative assessment of the contributions of insulin resistance and deficient beta-cell function to the fasting hyperglycaemia (homeostasis model assessment, HOMA). The accuracy and precision of the estimate have been determined by comparison with independent measures of insulin resistance and beta-cell function using hyperglycaemic and euglycaemic clamps and an intravenous glucose tolerance test. The estimate of insulin resistance obtained by homeostasis model assessment correlated with estimates obtained by use of the euglycaemic clamp (Rs = 0.88, p less than 0.0001), the fasting insulin concentration (Rs = 0.81, p less than 0.0001), and the hyperglycaemic clamp, (Rs = 0.69, p less than 0.01). There was no correlation with any aspect of insulin-receptor binding. The estimate of deficient beta-cell function obtained by homeostasis model assessment correlated with that derived using the hyperglycaemic clamp (Rs = 0.61, p less than 0.01) and with the estimate from the intravenous glucose tolerance test (Rs = 0.64, p less than 0.05). The low precision of the estimates from the model (coefficients of variation: 31% for insulin resistance and 32% for beta-cell deficit) limits its use, but the correlation of the model's estimates with patient data accords with the hypothesis that basal glucose and insulin interactions are largely determined by a simple feed back loop.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
15 Own result · 7 Own interpretation · 3 No full text of the sources · 1 Partly supported · 1 No basis given · accuracy not yet measured
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“The fasting plasma insulin concentration is largely determined by the glucose concentration [3]”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
What the sources say
- Partly supportedcites [3] McCarthy ST, Harris F, Turner RC (1977) Glucose control of basal insulin secretion in diabetes. Diabetologia 13: 93?97 sourceExperimental — accuracy not yet measured
The Results and Discussion (page unavailable in our copy) show that changing plasma glucose affects basal insulin secretion. But they also report markedly impaired responses in diabetic subjects, including cases where insulin remained nearly constant despite a substantial glucose decrease. The paper therefore supports glucose as an influence, but not the unqualified claim that it largely determines fasting insulin concentration. (LLM, conf=0.84)
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The estimate of deficient/3cell function obtained by homeostasis model assessment correlated with that derived using the hyperglycaemic clamp (R~ = 0.61, p< 0.01)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The estimate of insulin resistance obtained by homeostasis model assessment correlated with estimates obtained by use of the euglycaemic clamp (R~=0.88,p<0.0001)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“There was no correlation with any aspect of insulin-receptor binding.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“the fasting insulin concentration (P~ = 0.81, p < 0.0001)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The mean coefficient of variation over the two studies was 32%.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Reproducibility of estimate of /3-cell function by HOMA
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“in both groups together (1% 0.61, p < 0.01 : Fig. 3).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Comparisons of methods of assessing ~3-cell function
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“and with the estimate from the intravenous glucose tolerance test (R~ = 0.64, p < 0.05).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“and in both groups together: 1% = 0.64, p< 0.05; Fig. 3).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > HOMA compared with intravenous glucose tolerance test.
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Neither receptor numbers or any aspect of high or low affinity binding correlated with other measures of insulin resistance (HOMA, clamp, basal insulin or CIGMA: ~ all < 0.55; NS).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > HOMA compared with the hyperglycaemic clamp. The
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
- It may state two separate claims as one. 2
- The quote only partly states this claim. 1
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The low precision of the estimates from the model (coefficients of variation: 31% for insulin resistance and 32% for/3-cell deficit) limits its use”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The mean coefficient of variation over the two studies was 31%.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Hyperglycaemic clamp : ~-cell function (%)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The quote only partly states this claim.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“The degree of the hyperglycaemia does not correlate significantly with either the degrees of abnormal fl-cell function or insulin resistance.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Discussion
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
The authors state this as an assumption.
Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
“Assuming that normal-weight normal subjects aged < 35 years have 100% r-cell function, and an insulin resistance of 1, the values for a patient can be assessed from the insulin and glucose concentrations by the formulae: r-cell”
The paper relies on this without support.
The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
“The plasma glucose:insulin response for normal subjects, equivalent to the C-peptide response, is insulin = 5 (glucose-3.5).”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Surrogate markers of peripheral insulin activity, such as homeostasis model assessment and whole-body insulin sensitivity indexes, could be useful as well in the early identification of patients with IR, before overt DM sets in ().”
From Glucose Metabolism Abnormalities in Cushing Syndrome: From Molecular Basis to Clinical Management (2017) · cites this paper as [240]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“After the unprocessed diet, fasting glucose and insulin levels tended to decrease compared to baseline and the homeostasis model assessment of insulin resistance (HOMA-IR) (Matthews et al., 1985) was significantly decreased compared to baseline.”
From Ultra-Processed Diets Cause Excess Calorie Intake and Weight Gain: An Inpatient Randomized Controlled Trial of Ad Libitum Food Intake (2019) · cites this paper as Matthews et al., 1985
The cited source says what the claim attributes to it.
In the citing paper
“The Homeostasis Model Assessment of Insulin Resistance (HoMA-IR) was calculated according to Matthews et al. [25].”
From Chronotype: A Tool to Screen Eating Habits in Polycystic Ovary Syndrome? (2022) · cites this paper as [25]
The cited source says what the claim attributes to it.
In the citing paper
“AAV9-mTERT treated mice also showed a trend for an improved glucose uptake and a better homeostatic model assessment (HOMA (Heikkinen et al, 2007; Matthews et al, 1985)) compared to the AAV9-eGFP controls, although differences did not reach statistical significance (Supporting Information Fig S4D and E).”
From Telomerase gene therapy in adult and old mice delays aging and increases longevity without increasing cancer (2012) · cites this paper as Matthews et al, 1985
In the citing paper
“ndirect estimates of insulin resistance, such as HOMA-IR 63 and QUICKI, 64 are derived from fasting S-insulin and glucose concentrations and have been widely used in both nondiabetic and type 2 diabetic subjects as surrogates of insulin sensitivity.65,66”
From Increased liver fat, impaired insulin clearance, and hepatic and adipose tissue insulin resistance in type 2 diabetes. (2008) · cites this paper as [63]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Subjects and procedures
“The same 12 normal subjects and 11 Type 2 diabetic patients came to the hospital fasting on a separate day for a continuous infusion”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > HOMA compared with the hyperglycaemic clamp. The
“HOMA compared with CIGMA.The HOMA estimate of insulin resistance from the mean of 15 stressed fasting samples before the CIGMA correlated with that measured by CIGMA in 11 normal subjects (R~ = 0.69, p < 0.02), in 12 diabetic subjects (R~ 0.97, p < 0.0001)”
Citations
Cites
Glucose clamp technique: a method for quantifying insulin secretion and resistance.
DeFronzo, R. A., Tobin, J. D., & Andres, R. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.237.3.e214 · Cited by 7,425
Quantitative estimation of insulin sensitivity.
Bergman, R. N., Ider, Y. Z., Bowden, C. R., & Cobelli, C. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.236.6.e667 · Cited by 1,874 · cited 1×
“This use of modelling to provide a reference graph contrasts with other models where an individual patient's data have to be entered into a computer to determine the relationships between rapidly changing variables, such as occur after an intravenous glucose test [19].”
Method[WHO Expert Committee on diabetes mellitus].
Reitsma, W. D., & Terpstra, J. (1981) · PubMed · Cited by 556
Turner, R. C., Holman, R. R., Matthews, D., Hockaday, T. D. R., & Peto, J. (1979) · Metabolism · doi:10.1016/0026-0495(79)90146-x · Cited by 388
Self-citationCharacteristics of Human Erythrocyte Insulin Receptors
Gambhir, K. K., Archer, J. A., & BRADLEY, C. J. (1978) · Diabetes · doi:10.2337/diab.27.7.701 · Cited by 290
The Insulin Receptor: Its Role in Insulin Resistance of Obesity and Diabetes
Olefsky, J. M. (1976) · Diabetes · doi:10.2337/diab.25.12.1154 · Cited by 289
Hosker, J. P., Matthews, D. R., Rudenski, A. S., Burnett, M. A., Darling, P., Bown, E. G., & Turner, R. C. (1985) · Diabetologia · doi:10.1007/bf00280882 · Cited by 287
Self-citationPulsatile Insulin Has Greater Hypoglycemic Effect Than Continuous Delivery
Matthews, D. R., Naylor, B. A., Jones, R., Ward, G. M., & Turner, R. C. (1983) · Diabetes · doi:10.2337/diab.32.7.617 · Cited by 256
Self-citationControl of pulsatile insulin secretion in man
Matthews, D. R., Lang, D. A., Burnett, M. A., & Turner, R. C. (1983) · Diabetologia · doi:10.1007/bf00282705 · Cited by 175
Self-citationTHE BASAL PLASMA GLUCOSE: A SIMPLE RELEVANT INDEX OF MATURITY‐ONSET DIABETES
HOLMAN, R. R., & TURNER, R. C. (1981) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1981.tb00196.x · Cited by 64
Self-citation
Research works printed but not linked: 2
- Metropolitan Life Assurance Co (1959) Net weight standard for men and women. Stat Bull Metrol Life Found 40: 1?4
- Matthews DR, Hosker JP (1984) An unbiased, flexible computer programme for glucose clamping, with graphics and running statistics. Diabetologia 27: 308?309 A
Cited by
Sorted by citations
Items 19,401–19,500 of 31,469
Sevilla-González, M. D. R., Bourguet-Ramirez, B., Lazaro-Carrera, L. S., Martagón, A. J., Gómez‐Velasco, D., & Viveros-Ruiz, T. L. (2021) · JMIR Diabetes · doi:10.2196/25105 · Cited by 12
Schembre, S. M., Jospe, M. R., Bedrick, E. J., Li, L., Brewster, A. M., Levy, E. J., Dirba, D. D., Campbell, M., Taylor, R. W., & Basen‐Engquist, K. (2021) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-21-0298 · Cited by 12
Gong, S., Huo, S., Luo, Y., Li, Y., Ma, Y., Huang, X., Hu, M., Liu, W. Y., Zhang, R., Cai, X., et al. (2022) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3524 · Cited by 12
Okura, T., Fujioka, Y., Nakamura, R., Kitao, S., Ito, Y., Anno, M., Matsumoto, K., Shoji, K., Matsuzawa, K., Izawa, S., et al. (2022) · Scientific Reports · doi:10.1038/s41598-022-05704-y · Cited by 12
Lachâtre, M., Pasquet, A., Ajana, F., Soudan, B., Quertainmont, Y., Lion, G., Durand, E., Bocket, L., Mole, M., Cornavin, P., et al. (2022) · AIDS · doi:10.1097/qad.0000000000003176 · Cited by 12
Ong, Y. Y., Pang, W. W., Huang, J. Y., Aris, I. M., Sadananthan, S. A., Tint, M., Yuan, W. L., Chen, L., Chan, Y. H., Karnani, N., et al. (2022) · European Journal of Nutrition · doi:10.1007/s00394-022-02800-7 · Cited by 13
Serum Ferritin Levels Are Associated with Adipose Tissue Dysfunction-Related Indices in Obese Adults
Ding, X., Bian, N., Wang, J., Chang, X., An, Y., Wang, G., & Liu, J. (2022) · Biological Trace Element Research · doi:10.1007/s12011-022-03198-3 · Cited by 27
Milewska, E., Szczepanek‐Parulska, E., Marciniak, M., Krygier, A., Dobrowolska, A., & Ruchała, M. (2022) · Nutrients · doi:10.3390/nu14061307 · Cited by 13
Wang, W., Wang, Z., Ming, D., et al. (2022) · Journal of Animal Science · doi:10.1093/jas/skac033 · Cited by 12
Xu, Y., Cao, W., Shen, Y., Tang, J., Wang, Y., Ma, X., & Bao, Y. (2022) · BMC Endocrine Disorders · doi:10.1186/s12902-022-01002-w · Cited by 12
Interleukin 17, the double-edged sword in atherosclerosis
Moeinafshar, A., Razi, S., & Rezaei, N. (2022) · Immunobiology · doi:10.1016/j.imbio.2022.152220 · Cited by 12
Incidence of diabetes and its predictors in the Greater Beirut Area: a five-year longitudinal study
Nasrallah, M., Elbejjani, M., Nasreddine, L., Chami, H. A., Isma’eel, H., Fleifel, M., Chokor, F. A. Z., & Tamim, H. (2022) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-022-00833-w · Cited by 12
Perugini, J., Mercurio, E. D., Giuliani, A., Sabbatinelli, J., Bonfigli, A. R., Tortato, E., Severi, I., Cinti, S., Olivieri, F., le Roux, C. W., et al. (2022) · Scientific Reports · doi:10.1038/s41598-022-11942-x · Cited by 17
Impaired Brain Satiety Responses After Weight Loss in Children With Obesity
Roth, C. L., Melhorn, S. J., Leon, M. R. B. D., Rowland, M. G., Elfers, C., Huang, A., Saelens, B. E., & Schur, E. A. (2022) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgac299 · Cited by 14
Loai, S., Sun, X., Husain, M., Laflamme, M. A., Yeger, H., Nunes, S. S., & Cheng, H. M. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.886687 · Cited by 12
Mousavi, S. M., Heidarianpour, A., & Tavassoli, H. (2022) · Research Quarterly for Exercise and Sport · doi:10.1080/02701367.2022.2070116 · Cited by 12
Cao, W., Xu, Y., Shen, Y., Hu, T., Xiao, Y., Wang, Y., Ma, X., & Bao, Y. (2022) · International Journal of Obesity · doi:10.1038/s41366-022-01160-w · Cited by 13
Claypool, K. T., Long, M. T., & Patel, C. J. (2022) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2022.05.021 · Cited by 12
Nesfatin-1 – as a diagnosis regulatory peptide in type 2 diabetes mellitus
Kadim, B. M., & Hassan, E. A. (2022) · Journal of Diabetes & Metabolic Disorders · doi:10.1007/s40200-022-01070-8 · Cited by 12
Rezazadegan, M., Mirzaei, S., Asadi, A., Akhlaghi, M., & Saneei, P. (2022) · Scientific Reports · doi:10.1038/s41598-022-15018-8 · Cited by 12
Alonso-Bernáldez, M., Asensio, A., Palou-March, A., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23137237 · Cited by 12
Santos‐Báez, L. S., Garbarini, A., Shaw, D., Cheng, B., Popp, C. J., Manoogian, E. N. C., Panda, S., & Laferrère, B. (2022) · Contemporary Clinical Trials · doi:10.1016/j.cct.2022.106872 · Cited by 13
Liang, C.-W., Cheng, H.-Y., Lee, Y.-H., Liou, T., Liao, C., & Huang, S. (2022) · Nutrition Reviews · doi:10.1093/nutrit/nuac060 · Cited by 12
Factors Affecting Thyroid Elastography in Healthy Children and Patients with Hashimoto’s Thyroiditis
Koca, S. B., & Seber, T. (2022) · Journal of Clinical Research in Pediatric Endocrinology · doi:10.4274/jcrpe.galenos.2022.2022-4-5 · Cited by 12
Grigorescu, E.-D., Lăcătușu, C.-M., Floria, M., Cazac, G.-D., Onofriescu, A., Ceasovschih, A., Crețu, I., Mihai, B. M., & Șorodoc, L. (2022) · Journal of Personalized Medicine · doi:10.3390/jpm12091484 · Cited by 12
Quansah, D. Y., Schenk, S., Gilbert, L., Arhab, A., Gross, J., Marques-Vidal, P. M., Rodríguez, E. G., Hans, D. B., Horsch, A., & Puder, J. J. (2022) · Nutrients · doi:10.3390/nu14204272 · Cited by 11
Fatty Liver Is an Independent Risk Factor for Elevated Intraocular Pressure
Lee, J., Kwon, Y., Lee, H. S., et al. (2022) · Nutrients · doi:10.3390/nu14214455 · Cited by 12
Sun, J., Peng, S., Li, Z., Liu, F., Wu, C., Lu, Y., & Xiang, H. (2022) · Toxics · doi:10.3390/toxics10110663 · Cited by 12
Moxonidine ameliorates cardiac injury in rats with metabolic syndrome by regulating autophagy
El-Sayed, S. S., Rezq, S., Alsemeh, A. E., & Mahmoud, M. F. (2022) · Life Sciences · doi:10.1016/j.lfs.2022.121210 · Cited by 12
Gestational Diabetes Mellitus, Human Milk Composition, and Infant Growth
Dugas, C., Laberee, L., Perron, J., St‐Arnaud, G., Richard, V., Perreault, V., Leblanc, N., Marc, I., Marzo, V. D., Doyen, A., et al. (2022) · Breastfeeding Medicine · doi:10.1089/bfm.2022.0085 · Cited by 15
Zieleniak, A., Żurawska-Kliś, M., Cypryk, K., Woźniak, L. A., & Wójcik, M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232314677 · Cited by 14
The effects of oral trehalose in patients with diabetes: a pilot randomized controlled trial
Hashemian, S., Shojaei, M., Radbakhsh, S., et al. (2023) · Archives of Medical Science · doi:10.5114/aoms/159048 · Cited by 12
Wu, Y., Hui, Y., Liu, F., Chen, H., Liu, K., Chen, Q., He, Y., Hong, N., Yan, W., Kong, Q., et al. (2023) · Clinical Cosmetic and Investigational Dermatology · doi:10.2147/ccid.s396697 · Cited by 12
Chou, T.-J., Lu, C., Lin, L.-Y., Hsu, Y.-J., Huang, C., & Huang, K. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24065743 · Cited by 13
Wang, L., Pan, Y., Ye, X., Zhu, Y., Lian, Y., Zhang, H., Xu, M., Liu, M., & Ruan, X. (2023) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-023-01033-w · Cited by 12
Yang, L., Huang, H., Liu, Z., Ruan, J., & Xu, C. (2023) · Frontiers in Nutrition · doi:10.3389/fnut.2023.1162079 · Cited by 14
Wang, M., Zhou, M., Tan, Q., Yu, L., Dong, C., Liang, R., Liu, W., Zhang, Y., Li, M., Nie, X., et al. (2023) · Environmental Pollution · doi:10.1016/j.envpol.2023.121833 · Cited by 12
Weight retention and glucose intolerance in early postpartum after gestational diabetes
Minschart, C., Myngheer, N., Maes, T., Block, C. E. M. D., Pottelbergh, I. V., Abrams, P. J., Vinck, W. J., Leuridan, L., Driessens, S., Mathieu, C., et al. (2023) · European Journal of Endocrinology · doi:10.1093/ejendo/lvad053 · Cited by 14
Metabolic Syndrome Screening and Nutritional Status of Patients with Psoriasis: A Scoping Review
Haris, N. H. M., Krishnasamy, S., Chin, K., Mariappan, V., & Arumugam, M. (2023) · Nutrients · doi:10.3390/nu15122707 · Cited by 13
Silva, T. O., Norde, M. M., Vasques, A. C. J., Zambon, M. P., Antônio, M. Â. R. D. G. M., Rodrigues, A. M. D. B., BRAMS group, Geloneze, B., & Brazilian Metabolic Syndrome Study investigators (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1191935 · Cited by 15
Mahalingam, D., Hanni, S., Serritella, A. V., Fountzilas, C. K., Michalek, J. E., Hernandez, B. S., Sarantopoulos, J., Datta, P., Romero, O., Pillai, S. M. A., et al. (2023) · Oncotarget · doi:10.18632/oncotarget.28458 · Cited by 14
Gojda, J., Koudelková, K., Ouřadová, A., Lang, A., Krbcová, M., Gvozdeva, A., Šebo, V., Slagmolen, L., Potočková, J., Tůma, P., et al. (2023) · Nutrition and Diabetes · doi:10.1038/s41387-023-00241-7 · Cited by 13
Berezina, T. A., Fushtey, I. M., Berezin, A. A., Pavlov, S. V., & Berezin, A. Е. (2023) · Advances in Therapy · doi:10.1007/s12325-023-02683-y · Cited by 12
Marcovecchio, M. L., Gravina, M., Gallina, S., D’Adamo, E., Caterina, R. D., Chiarelli, F., Mohn, A., & Renda, G. (2015) · European Journal of Pediatrics · doi:10.1007/s00431-015-2608-3 · Cited by 12
Yamauchi, K., Sato, Y., Nakasone, Y., & Aizawa, T. (2015) · Diabetologia · doi:10.1007/s00125-015-3612-x · Cited by 14
Hamed, H. O. (2013) · Journal of obstetrics and gynaecology research · doi:10.1111/jog.12101 · Cited by 12
Kim, T. H., Eom, J. S., Lee, C. G., Yang, Y. M., Lee, Y. S., & Kim, S. G. (2012) · British Journal of Pharmacology · doi:10.1111/bph.12057 · Cited by 12
Li, M., Zhou, H., Guan, Y., et al. (2015) · Journal of Diabetes · doi:10.1111/1753-0407.12317 · Cited by 12
de Luis, D. A., Aller, R., Izaola, O., de la Fuente, B., Primo, D., Conde, R., & Sagrado, M. G. (2013) · Annals of Nutrition and Metabolism · doi:10.1159/000356710 · Cited by 13
Yan, Y., Ma, R., Ding, Y., Guo, H., Zhang, J., Mu, L., Zhang, M., Liu, J., Rui, D., He, J., et al. (2015) · Mediators of Inflammation · doi:10.1155/2015/706768 · Cited by 12
Biochemical Efficacy of Nigella Sativa Oil and Metformin on Induced Diabetic Male Rats
Mahmoud, Y. K., Saleh, S. Y., El-Ghannam, A. E.-R. A., & Ibrahim, I. A. (2014) · American Journal of Animal and Veterinary Sciences · doi:10.3844/ajavsp.2014.277.284 · Cited by 12
Sakr, H. F., Al-Hashem, F. H., El-Naby, W. M. H., Alkhateeb, M. A., Zaki, M. S. A., Refaey, H. E., & Morsy, M. D. (2013) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/cjpp-2013-0043 · Cited by 12
Chinedu., A. A., Salako, O. A., & Olaide., A. O. (2015) · doi:10.11648/j.jps.s.2014020601.12 · Cited by 12
[Metabolic syndrome is associated with cardiovascular events in haemodialysis].
de José, A. P., Verdalles-Guzmán, Ú., Abad, S., et al. (2014) · PubMed · doi:10.3265/nefrologia.pre2013.oct.12092 · Cited by 12
Li, M., Reynolds, C. M., Gray, C. L., & Vickers, M. H. (2015) · Endocrinology · doi:10.1210/en.2015-1041 · Cited by 12
Rhee, E., Park, S. E., Chang, Y., Ryu, S., & Lee, W. (2015) · Metabolism · doi:10.1016/j.metabol.2015.10.005 · Cited by 12
Yüksel, M. A., Davutoğlu, E. A., Yüksel, İ. T., et al. (2015) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.3109/14767058.2015.1092958 · Cited by 12
de Luis, D. A., Izaola, O., Aller, R., Fuente, B. D. L., & Pacheco, D. (2013) · Journal of Endocrinological Investigation · doi:10.1007/bf03346760 · Cited by 12
MRI-diagnosed Nonalcoholic Fatty Liver Disease Is Correlated to Insulin Resistance in Adolescents
do Nascimento, J. H. R., Epifânio, M., Soder, R. B., & Baldisserotto, M. (2013) · Academic Radiology · doi:10.1016/j.acra.2013.08.016 · Cited by 12
Lee, S., Hong, H., Han, T., & Kang, H. (2015) · Biology of Sport · doi:10.5604/20831862.1150298 · Cited by 12
Takaya, J., Yamanouchi, S., & Kaneko, K. (2014) · PLoS ONE · doi:10.1371/journal.pone.0084125 · Cited by 14
Choi, E.-S., Rhee, E., Choi, J., Bae, J.-C., Yoo, S.-H., Kim, W., Park, S., Park, C., Lee, W., Cho, Y.-K., et al. (2010) · Korean Diabetes Journal · doi:10.4093/kdj.2010.34.5.287 · Cited by 12
Strack, C., Baessler, A., Wagner, F. M., Bruxmeier, J., Yaroslavskyy, O., Rousseva, E., Loew, T. H., Riegger, G. A. J., Schmitz, G., & Fischer, M. (2012) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.10918 · Cited by 12
Lopes, F. G., Bottino, D. A., de Oliveira, F. J., Mecenas, A. S., Clapauch, R., & Bouskela, E. (2012) · Microvascular Research · doi:10.1016/j.mvr.2012.10.009 · Cited by 12
ACE gene polymorphism and cardiac structure in patients with insulin resistance
Akın, F., Turgut, S., Dursunoğlu, D., et al. (2008) · Molecular Biology Reports · doi:10.1007/s11033-008-9222-7 · Cited by 12
Prevalence of hyperthyrotropinemia in obese children before and after weight loss
Baş, V. N., Aycan, Z., Ağladıoğlu, S. Y., & Kendırcı, H. N. P. (2013) · Eating and Weight Disorders - Studies on Anorexia Bulimia and Obesity · doi:10.1007/s40519-013-0008-0 · Cited by 12
Banasik, K., Hollensted, M., Galijatovic, E. A. A., et al. (2012) · BMC Medical Genetics · doi:10.1186/1471-2350-13-10 · Cited by 12
Apolipoprotein B is a better marker than non-HDL-cholesterol for the metabolic syndrome in Koreans
Han, J. H., Park, H. S., Kim, J., & Kim, S. M. (2007) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2007.05.021 · Cited by 12
Gutiérrez‐Repiso, C., Rojo‐Martínez, G., Soriguer, F., García‐Fuentes, E., Vendrell, J. J., Vázquez, J. A., Valdés, S., Urrutia, I., Serrano‐Ríos, M., Pascual-Manich, G., et al. (2012) · Clinical Science · doi:10.1042/cs20120261 · Cited by 12
Rubattu, S., Barbato, A., Marchitti, S., Iacone, R., Castro, S. D., Evangelista, A., Stanzione, R., Ippolito, R., Sciarretta, S., Palmieri, L., et al. (2010) · Journal of Hypertension · doi:10.1097/hjh.0b013e32833a39aa · Cited by 12
Celik, C., Abalı, R., Güzel, S., Baştu, E., Küçükyalçın, V., & Yılmaz, M. (2012) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2012.04437.x · Cited by 12
Fujii, T. M. D. M., Jacob, P., Yamada, M., Borges, M. C., Norde, M. M., Pantaleão, L. C., de Oliveira, D. M., Tirapegui, J., de Castro, I. A., Borelli, P., et al. (2014) · International Journal of Food Sciences and Nutrition · doi:10.3109/09637486.2014.945153 · Cited by 12
Kosmiski, L. A., Bessesen, D. H., STOTZ, S. A., Koeppe, J. R., & Horton, T. J. (2007) · Metabolism · doi:10.1016/j.metabol.2006.10.012 · Cited by 12
de Luis, D. A., Aller, R., Izaola, O., et al. (2007) · Medicina Clínica · doi:10.1157/13110463 · Cited by 12
Effects of Growth Hormone (GH) on Ghrelin, Leptin, and Adiponectin in GH-Deficient Patients
m, B. E. N. E., Burman, P., Holdstock, C., & Karlsson, F. A. (2004) · Obstetrical & Gynecological Survey · doi:10.1097/00006254-200406000-00018 · Cited by 12
Rondó, P. H. D. C., Pereira, J. A., & Lemos, J. O. (2013) · European Journal of Clinical Nutrition · doi:10.1038/ejcn.2013.75 · Cited by 12
Li, H., Zhu, X., Wang, A., Wang, G., & Zhang, Y. (2012) · Hypertension Research · doi:10.1038/hr.2011.229 · Cited by 12
Paldánius, P. M., Ivaska, K. K., Hovi, P., ANDERSSON, S. M., Eriksson, J. G., Väänänen, K., Kajantie, E., & Mäkitie, O. (2013) · PLoS ONE · doi:10.1371/journal.pone.0063036 · Cited by 12
Different Impacts of Metabolic Syndrome Components on Insulin Resistance in Type 2 Diabetes
Hsu, C.-H. (2013) · International Journal of Endocrinology · doi:10.1155/2013/740419 · Cited by 12
Dietary, Lifestyle, and Health Correlates of Overweight and Obesity in Adults 19 to 39 Years of Age
O’Neil, C. E., Deshmukh-Taskar, P., Mendoza, J. A., Nicklas, T. A., Liu, Y., Relyea, G. E., & Berenson, G. S. (2011) · American Journal of Lifestyle Medicine · doi:10.1177/1559827611404923 · Cited by 12
Deveer, R., Üstün, Y. E., Uysal, S., Su, F. A., Sarıaslan, S., Gülerman, C., & Mollamahmutoğlu, L. (2012) · Gynecological Endocrinology · doi:10.3109/09513590.2011.650758 · Cited by 12
Insulin resistance in pre-school very-low-birth weight pre-term children
Bo, S., Bertino, E., Bagna, R., Trapani, A., Gambino, R., Martano, C., Mombrò, M., & Pagano, G. (2006) · Diabetes & Metabolism · doi:10.1016/s1262-3636(07)70262-8 · Cited by 12
Chen, J.-G., Spagnoli, A., & Torquati, A. (2012) · Surgical Endoscopy · doi:10.1007/s00464-012-2353-x · Cited by 12
Gatti, C. M. I., Suhas, E., Côté, S., Laouan-Sidi, E. A., Dewailly, É., & Lucas, M. (2014) · Journal of Adolescent Health · doi:10.1016/j.jadohealth.2014.09.001 · Cited by 12
van der Wijden, C. L., de Waal, H. A. D., van Mechelen, W., & van Poppel, M. N. M. (2014) · Clinical Endocrinology · doi:10.1111/cen.12593 · Cited by 13
Bone mass and bone metabolic indices in male master rowers
Śliwicka, E., Nowak, A., Zep, W., Leszczyński, P., & Pilaczyńska-Szczȩśniak, Ł. (2014) · Journal of Bone and Mineral Metabolism · doi:10.1007/s00774-014-0619-1 · Cited by 12
Helge, J. W., Tobin, L., Drachmann, T., Hellgren, L. I., Dela, F., & Galbo, H. (2011) · European Journal of Applied Physiology · doi:10.1007/s00421-011-2041-x · Cited by 12
Hao, Y., Ma, X., Luo, Y., Ni, J., Dou, J., Zhu, J., Bao, Y., & Jia, W. (2014) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/1440-1681.12200 · Cited by 12
Chitin enhances obese inflammation ex vivo
Huang, C., Beasley, K. N., Acevedo, E. O., Franco, R. L., Jones, T. L., Mari, D. C., & Shibata, Y. (2013) · Human Immunology · doi:10.1016/j.humimm.2013.09.005 · Cited by 12
Elhddad, A. S., Fairlie, F., & Lashen, H. (2014) · Acta Obstetricia Et Gynecologica Scandinavica · doi:10.1111/aogs.12427 · Cited by 12
Sato, R., Watanabe, H., Shirai, K., Ohki, S., Genma, R., Morita, H., Inoue, E., Takeuchi, M., Maekawa, M., & Nakamura, H. (2012) · BMJ Open · doi:10.1136/bmjopen-2011-000327 · Cited by 12
Ferrer, F., Nazih, H., Zaïr, Y., et al. (2003) · Metabolism · doi:10.1016/j.metabol.2003.07.004 · Cited by 12
Spectre étiologique des hyperferritinémies
Lepage, L., Leflon, P., Mahévas, M., et al. (2005) · La Revue de Médecine Interne · doi:10.1016/j.revmed.2005.01.005 · Cited by 12
Anger, adiposity, and glucose control in nondiabetic adults: findings from MIDUS II
Tsenkova, V. K., Carr, D., Coe, C. L., & Ryff, C. D. (2012) · Journal of Behavioral Medicine · doi:10.1007/s10865-012-9460-y · Cited by 12
Menopausal hot flashes and insulin resistance
Tuomikoski, P., Ylikorkala, O., & Mikkola, T. S. (2012) · Menopause The Journal of The North American Menopause Society · doi:10.1097/gme.0b013e3182503d5d · Cited by 12
Postprandial metabolic heterogeneity in men with primary dyslipidaemia
Pavlidis, A. N., Kolovou, G. D., Anagnostopoulou, K. K., Petrou, P. C., & Cokkinos, D. V. (2010) · Archives of Medical Science · doi:10.5114/aoms.2010.19295 · Cited by 12
Gonadal dysfunction in morbidly obese adolescent girls
Chin, V. L., Censani, M., Lerner, S. E., Conroy, R., Oberfield, S. E., McMahon, D. J., Zitsman, J. L., & Fennoy, I. (2014) · Fertility and Sterility · doi:10.1016/j.fertnstert.2013.12.046 · Cited by 12
Bose, K. S. C., Gupta, S. K., & Vyas, P. (2012) · Experimental Diabetes Research · doi:10.1155/2012/386524 · Cited by 12
Rueda, M. S., Herencia, J. A. C., Orozco, J. M., et al. (2011) · Endocrinología y Nutrición · doi:10.1016/j.endonu.2011.06.003 · Cited by 12
Walraven, I., Riet, E. V. ‘., Stehouwer, C. D. A., Polak, B. C. P., Moll, A. C., Dekker, J. M., & Nijpels, G. (2013) · Diabetologia · doi:10.1007/s00125-013-2864-6 · Cited by 12
Metadata
- Authors
- Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F., & Turner, R. C.
- Affiliations
- University of Oxford (GB)
- ORCID
- Matthews, D. R.
- Venue
- Diabetologia
- Published
- 1985-07
- Volume
- 28
- Issue
- 7
- Pages
- 412-419
- ISSN
- 0012-186X (ISSN-L)
- 1432-0428
- OpenAlex
- W2160234571
- Cited by
- 31,502
- References
- 21
- Citations by year
- 2026: 933 · 2025: 1060 · 2024: 1240 · 2023: 1291 · 2022: 1489 · 2021: 1528 · 2020: 1424 · 2019: 1427 · 2018: 1456 · 2017: 1440 · 2016: 1481 · 2015: 1682 · 2014: 1693 · 2013: 1621 · 2012: 1518
- FWCI
- 7.91
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Diabetologia (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Medical Research Council
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- HOMA, insulin resistance, beta-cell function, fasting blood glucose, fasting insulin, hyperglycaemic clamp, euglycaemic clamp, intravenous glucose tolerance test, insulin receptor binding, type 2 diabetes
- MeSH terms
- Adult, Blood Glucose, Computers, Diabetes Mellitus, Type 2, Erythrocytes, Fasting, Homeostasis, Humans, Insulin, Insulin Resistance, Islets of Langerhans, Middle Aged, Monocytes, Receptor, Insulin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-10-14, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-14 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
